Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-025499

CHIEF MEDICAL OFFICER sold 816 shares at $30.00 ($24,482)

  • CHIEF MEDICAL OFFICER acquired 816 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Collins Helen Louise · CHIEF MEDICAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-18 Exercise or conversion : show line 1 in the form 10b5-1 +816 $2.48 $2,024 816 D
2024-10-18 Sale : show line 2 in the form 10b5-1 −816 $30.00 $24,482 0 D
Open-market sales · 816 sh · avg $30.00 · $24,482

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-18 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −816 266,268 D
Loading xslF345X05/form4-10222024_081038.xml…